GlassScriptPhysician profile
Danielle Matwijec
NPI 1194294306
$2,212.55
in general payments reported to CMS, 2019-2025
18 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $285 · 2023: $437 · 2024: $692 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $256.10 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.28 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $190.01 | 2023-2024 | Fasenra |
| E.R. Squibb & Sons, L.L.C. | $139.93 | 2021-2023 | Eliquis |
| Gilead Sciences, INC. | $125.00 | 2024 | Descovy |
| Avadel Cns Pharmaceuticals, LLC | $125.00 | 2025 | Lumryz |
| Mylan Specialty L.P. | $125.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.00 | 2024 | |
| Insulet Corporation | $113.08 | 2025 | Omnipod |
| Dexcom, INC. | $106.64 | 2024 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $100.86 | 2023 | Dupixent |
| Novo Nordisk INC | $100.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2024 | Lifevest |
| Lilly USA, LLC | $99.18 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $88.04 | 2023 | Bexsero |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $83.22 | 2022 | |
| Merck Sharp & Dohme LLC | $81.38 | 2023 | Verquvo |
| Exact Sciences Corporation | $20.83 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Matwijec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.